Pharmacokinetics in Healthy Adults Clinical Trial
Official title:
A Single-Dose, Randomized, Three-way, Partially Blinded Crossover Study to Compare the Pharmacokinetics and Bioavailability of Ceftriaxone Administered as a 1 Gram Intravenous Infusion, a 1 Gram Subcutaneous Infusion and a 2 Gram Subcutaneous Infusion in Healthy Adult Subjects
The proposed study aims to assess the time above MIC (4 mg/mL), and the pharmacokinetics/pharmacodynamics and bioavailability of 1 g ceftriaxone administered by constant rate subcutaneous infusion over 2 hours compared with 1 g of ceftriaxone administered as a constant IV infusion over 0.5 hours. In addition, the study will compare the results obtained after 1 g ceftriaxone intravenous or subcutaneous administration with 2 g ceftriaxone administered subcutaneously
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05032833 -
Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT05347849 -
Single Ascending Dose Study With BPL-003 in Healthy Subjects
|
Phase 1 |